Alternatives to Measured

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

Both molecules now have confirmed, tiered pricing — $199-249/mo semaglutide, $299-356/mo tirzepatide, depending on plan length — found by walking the actual intake, since the public pages still carry no price at all.

Semaglutide runs $199/mo month-to-month and tirzepatide $299, falling to $99 and $159 only if you prepay a full year. Provider review takes about 24 hours and delivery 2-3 days, both published, and the site names its pharmacies, its clinical group and its chief medical officer. The middle of the ladder is where it gets slippery: the 6-month rates are introductory and renew higher.

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

The widest menu on the board — compounded, oral and four brand pens, all on a chat visit with no camera — sold behind a pricing page that quotes you a monthly figure for a plan you have to pay for a year in advance.

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.